Larsen Amends VirnetX 13D Filing

TL;DR

Larsen updated his VirnetX 13D filing, date changed to Nov 12.

AI Summary

Kendall Larsen filed an amendment (No. 6) to Schedule 13D on November 14, 2024, regarding VirnetX Holding Corp. The filing indicates a change in the date of the event requiring this statement to November 12, 2024. Larsen is listed as the person authorized to receive notices and communications for this filing.

Why It Matters

This amendment signals a potential shift in significant ownership or control of VirnetX Holding Corp, requiring investor attention.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased volatility and strategic shifts for the company.

Key Numbers

• 6 — Amendment Number (Indicates this is the sixth amendment to the original filing.)
• November 12, 2024 — Date of Event (The date triggering the requirement for this filing amendment.)
• November 14, 2024 — Filing Date (The date the amendment was submitted to the SEC.)

Key Players & Entities

• Kendall Larsen (person) — Filing person and authorized contact
• VirnetX Holding Corp (company) — Subject company
• 308 Dorla Court, Suite 206 Zephyr Cove, Nevada (address) — Address of Kendall Larsen

FAQ

Key Financial Figures

• $0.0001 — ration (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securitie

Filing Documents

• ef20038709_sc13da.htm (SC 13D/A) — 49KB
• 0001140361-24-046984.txt ( ) — 51KB

of the Amended Schedule 13D is hereby amended and restated in its entirety as follows

Item 1 of the Amended Schedule 13D is hereby amended and restated in its entirety as follows: This Amendment 6 relates to the common stock, par value $0.0001 per share (the "Common Stock"), of VirnetX Holding Corporation (the "Issuer"). The address of the principal executive office of the Issuer is: VirnetX Holding Corporation, 308 Dorla Court, Suite 206, Zephyr Cove, Nevada 89448. Item 5. Interest in Securities of the Issuer Item 5 of the Original Schedule 13D is hereby amended and restated in its entirety and presented on a post-split basis as follows: (a) The aggregate number of shares of the Issuer's Common Stock beneficially owned by the Reporting Person is 521,594, which represents beneficial ownership of approximately 13.8% of the Issuer's Common Stock. (b) The Reporting Person has the sole power to vote, or to direct the vote, and to dispose, or to direct the disposition of 405,444 shares of Issuer's Common Stock beneficially owned by the Reporting Person. The Reporting Person has the shared power to vote, or to direct the vote, and to dispose, or to direct the disposition of 15,000 shares of the Issuer's Common Stock held of record by K2 Investment Fund LLC of which the Reporting Person and Ms. Kathleen Larsen (the "Spouse") are the sole member-managers, 74,147 shares of the Issuer's Common Stock held by the Spouse, and 27,003 shares of the Issuer's Common Stock issuable pursuant to options exercisable within 60 days of November 12, 2024 held by the Spouse. The holdings reported in this Amendment 6 excludes (i) 30,676 shares of Common Stock held by the Spouse's revocable trust; (ii) any shares of Common Stock or shares of Common Stock issuable pursuant to options that are presently exercisable or exercisable within 60 days of November 12, 2024 held by an adult child of the Spouse; and (iii) any shares of Common Stock held by an adult child of the Spouse in an irrevocable trust. The Reporting Person disclaims beneficial ownership of the excluded sha

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: November 14, 2024 /s/ Kendall Larsen Kendall Larsen Chief Executive Officer, President and Director

View Full Filing

View this SC 13D/A filing on SEC EDGAR